Expression of thrombin receptors in endothelial cells and neutrophils from normal and preeclamptic pregnancies
- PMID: 12161502
- DOI: 10.1210/jcem.87.8.8727
Expression of thrombin receptors in endothelial cells and neutrophils from normal and preeclamptic pregnancies
Abstract
Thrombin receptors, i.e. proteinase-activated receptors (PARs), are expressed in endothelial cells (ECs) and neutrophils and directly affect platelet function and thrombosis. Although endothelial dysfunction and neutrophil activation have been demonstrated in women with preeclampsia (PE), the expression and regulation of PARs have not been defined in PE. In this study, we measured the expression of PARs in ECs and in neutrophils derived from normal and preeclamptic pregnancies. We also examined the effects of placental factors on PAR expression in these cells in vitro. ECs were isolated from umbilical cords (human umbilical vein ECs) from normal and preeclamptic pregnancies. Neutrophils were isolated from blood obtained from nonpregnant, uncomplicated pregnant, and preeclamptic women. Total RNA was extracted from the first-passage (P1) ECs (normal and PE) and from normal P1 ECs incubated with conditioned media derived from normal and preeclamptic placental cultures. The mRNA expression of thrombin receptor (PAR1), PAR2, and PAR3 was measured by ribonuclease protective assay. The expression of glyceraldehyde 3-phosphate dehydrogenase was used as an internal control for each sample. We found that: 1) PAR1 expression was enhanced in ECs from PE, compared with ECs from normal pregnancies; 2) PAR2 expression was expressed in PE ECs but not in normal ECs; 3) neutrophils from nonpregnant women, normal, and preeclamptic pregnancies expressed PAR2, whereas only neutrophils from normal and preeclamptic pregnancies expressed PAR1; and 4) factors released from preeclamptic placenta up-regulated PAR1 and PAR2 expression in ECs but not in neutrophils. We conclude that mRNA expression of PAR1 and PAR2 is increased in ECs derived from preeclamptic pregnancies. Up-regulation of thrombin receptor expression in neutrophils may be a unique phenomenon during pregnancy but not apparently unique to PE. Factors released from the placenta are likely candidates in regulating PAR expression in ECs and may contribute to the platelet activation and vascular endothelial dysfunction in PE.
Similar articles
-
Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia.J Soc Gynecol Investig. 1999 May-Jun;6(3):136-41. doi: 10.1016/s1071-5576(99)00004-0. J Soc Gynecol Investig. 1999. PMID: 10376269
-
Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro.Placenta. 2001 Jul;22(6):560-5. doi: 10.1053/plac.2001.0691. Placenta. 2001. PMID: 11440544
-
Protease chymotrypsin mediates the endothelial expression of P- and E-selectin, but not ICAM and VCAM, induced by placental trophoblasts from pre-eclamptic pregnancies.Placenta. 2003 Sep-Oct;24(8-9):851-61. doi: 10.1016/s0143-4004(03)00132-2. Placenta. 2003. PMID: 13129682
-
Pregnancy programming and preeclampsia: identifying a human endothelial model to study pregnancy-adapted endothelial function and endothelial adaptive failure in preeclamptic subjects.Adv Exp Med Biol. 2014;814:27-47. doi: 10.1007/978-1-4939-1031-1_4. Adv Exp Med Biol. 2014. PMID: 25015799 Review.
-
Pregnancy, programming and preeclampsia: gap junctions at the nexus of pregnancy-induced adaptation of endothelial function and endothelial adaptive failure in PE.Curr Vasc Pharmacol. 2013 Sep;11(5):712-29. doi: 10.2174/1570161111311050009. Curr Vasc Pharmacol. 2013. PMID: 24063383 Review.
Cited by
-
High-altitude hypoxia and preeclampsia.Front Biosci. 2007 May 1;12:2967-77. doi: 10.2741/2286. Front Biosci. 2007. PMID: 17485273 Free PMC article. Review.
-
Targeting Neutrophil Extracellular Trap Formation: Exploring Promising Pharmacological Strategies for the Treatment of Preeclampsia.Pharmaceuticals (Basel). 2024 May 9;17(5):605. doi: 10.3390/ph17050605. Pharmaceuticals (Basel). 2024. PMID: 38794175 Free PMC article. Review.
-
Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia?Am J Obstet Gynecol. 2022 Feb;226(2S):S945-S953. doi: 10.1016/j.ajog.2021.11.1367. Am J Obstet Gynecol. 2022. PMID: 35177224 Free PMC article. Review.
-
Gene Expression of Pregnancy Neutrophils Differs for Protease versus Lipopolysaccharide Stimulation.Int J Mol Sci. 2022 Apr 28;23(9):4924. doi: 10.3390/ijms23094924. Int J Mol Sci. 2022. PMID: 35563315 Free PMC article.
-
Proteases Activate Pregnancy Neutrophils by a Protease-Activated Receptor 1 Pathway: Epigenetic Implications for Preeclampsia.Reprod Sci. 2020 Nov;27(11):2115-2127. doi: 10.1007/s43032-020-00232-4. Epub 2020 Jun 15. Reprod Sci. 2020. PMID: 32542542 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous